Burkett Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3K Hold
39
﹤0.01% 234
2026
Q1
$2.4K Hold
39
﹤0.01% 214
2025
Q4
$2.11K Hold
39
﹤0.01% 206
2025
Q3
$1.74K Sell
39
-387
-91% -$18.1K ﹤0.01% 200
2025
Q2
$19.7K Buy
426
+6
+1% +$295 0.01% 127
2025
Q1
$25.6K Buy
420
+4
+1% +$233 0.01% 122
2024
Q4
$23.5K Buy
416
+4
+1% +$223 0.01% 115
2024
Q3
$21.3K Sell
412
-189
-31% -$8.87K 0.01% 112
2024
Q2
$24.9K Sell
601
-1,075
-64% -$48.1K 0.01% 108
2024
Q1
$90.9K Buy
1,676
+20
+1% +$1.02K 0.05% 63
2023
Q4
$85K Buy
+1,656
New +$86.9K 0.05% 65

Other funds holding BMY

Burkett Financial Services's BMY Position: Q2 2026 in Review

Burkett Financial Services held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 39 shares worth $2.3K. The position accounts for ﹤0.01% of the portfolio, ranked #234.

Burkett Financial Services first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $90.9K in Q1 2024. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Burkett Financial Services held 39 shares of Bristol-Myers Squibb worth $2.3K as of Q2 2026.
  • Burkett Financial Services left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Burkett Financial Services's portfolio in Q2 2026, its #234 holding.
  • Burkett Financial Services first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Burkett Financial Services's Bristol-Myers Squibb position peaked at $90.9K in Q1 2024.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Burkett Financial Services's 13F filing for Q2 2026, filed 2 Jul 2026.